163 related articles for article (PubMed ID: 19736945)
1. Why the extended-spectrum beta-lactamases SHV-2 and SHV-5 are "hypersusceptible" to mechanism-based inhibitors.
Kalp M; Bethel CR; Bonomo RA; Carey PR
Biochemistry; 2009 Oct; 48(41):9912-20. PubMed ID: 19736945
[TBL] [Abstract][Full Text] [Related]
2. Different intermediate populations formed by tazobactam, sulbactam, and clavulanate reacting with SHV-1 beta-lactamases: Raman crystallographic evidence.
Kalp M; Totir MA; Buynak JD; Carey PR
J Am Chem Soc; 2009 Feb; 131(6):2338-47. PubMed ID: 19161282
[TBL] [Abstract][Full Text] [Related]
3. Raman crystallographic studies of the intermediates formed by Ser130Gly SHV, a beta-lactamase that confers resistance to clinical inhibitors.
Helfand MS; Taracila MA; Totir MA; Bonomo RA; Buynak JD; van den Akker F; Carey PR
Biochemistry; 2007 Jul; 46(29):8689-99. PubMed ID: 17595114
[TBL] [Abstract][Full Text] [Related]
4. Effect of the inhibitor-resistant M69V substitution on the structures and populations of trans-enamine beta-lactamase intermediates.
Totir MA; Padayatti PS; Helfand MS; Carey MP; Bonomo RA; Carey PR; van den Akker F
Biochemistry; 2006 Oct; 45(39):11895-904. PubMed ID: 17002290
[TBL] [Abstract][Full Text] [Related]
5. High resolution crystal structures of the trans-enamine intermediates formed by sulbactam and clavulanic acid and E166A SHV-1 {beta}-lactamase.
Padayatti PS; Helfand MS; Totir MA; Carey MP; Carey PR; Bonomo RA; van den Akker F
J Biol Chem; 2005 Oct; 280(41):34900-7. PubMed ID: 16055923
[TBL] [Abstract][Full Text] [Related]
6. Sulbactam forms only minimal amounts of irreversible acrylate-enzyme with SHV-1 beta-lactamase.
Totir MA; Helfand MS; Carey MP; Sheri A; Buynak JD; Bonomo RA; Carey PR
Biochemistry; 2007 Aug; 46(31):8980-7. PubMed ID: 17630699
[TBL] [Abstract][Full Text] [Related]
7. Detecting a quasi-stable imine species on the reaction pathway of SHV-1 β-lactamase and 6β-(hydroxymethyl)penicillanic acid sulfone.
Che T; Rodkey EA; Bethel CR; Shanmugam S; Ding Z; Pusztai-Carey M; Nottingham M; Chai W; Buynak JD; Bonomo RA; van den Akker F; Carey PR
Biochemistry; 2015 Jan; 54(3):734-43. PubMed ID: 25536850
[TBL] [Abstract][Full Text] [Related]
8. Tazobactam forms a stoichiometric trans-enamine intermediate in the E166A variant of SHV-1 beta-lactamase: 1.63 A crystal structure.
Padayatti PS; Helfand MS; Totir MA; Carey MP; Hujer AM; Carey PR; Bonomo RA; van den Akker F
Biochemistry; 2004 Feb; 43(4):843-8. PubMed ID: 14744126
[TBL] [Abstract][Full Text] [Related]
9. Penam sulfones and β-lactamase inhibition: SA2-13 and the importance of the C2 side chain length and composition.
Rodkey EA; Winkler ML; Bethel CR; Pagadala SR; Buynak JD; Bonomo RA; van den Akker F
PLoS One; 2014; 9(1):e85892. PubMed ID: 24454944
[TBL] [Abstract][Full Text] [Related]
10. Aspartic acid for asparagine substitution at position 276 reduces susceptibility to mechanism-based inhibitors in SHV-1 and SHV-5 beta-lactamases.
Giakkoupi P; Tzelepi E; Legakis NJ; Tzouvelekis LS
J Antimicrob Chemother; 1999 Jan; 43(1):23-9. PubMed ID: 10381097
[TBL] [Abstract][Full Text] [Related]
11. Following the reactions of mechanism-based inhibitors with beta-lactamase by Raman crystallography.
Helfand MS; Totir MA; Carey MP; Hujer AM; Bonomo RA; Carey PR
Biochemistry; 2003 Nov; 42(46):13386-92. PubMed ID: 14621983
[TBL] [Abstract][Full Text] [Related]
12. Role of Ser-238 and Lys-240 in the hydrolysis of third-generation cephalosporins by SHV-type beta-lactamases probed by site-directed mutagenesis and three-dimensional modeling.
Huletsky A; Knox JR; Levesque RC
J Biol Chem; 1993 Feb; 268(5):3690-7. PubMed ID: 8429044
[TBL] [Abstract][Full Text] [Related]
13. Why tazobactam and sulbactam have different intermediates population with SHV-1 β-lactamase: a molecular dynamics study.
Li R; Wang YT; Chen CL
J Mol Model; 2013 Jun; 19(6):2519-24. PubMed ID: 23455927
[TBL] [Abstract][Full Text] [Related]
14. Rational design of a beta-lactamase inhibitor achieved via stabilization of the trans-enamine intermediate: 1.28 A crystal structure of wt SHV-1 complex with a penam sulfone.
Padayatti PS; Sheri A; Totir MA; Helfand MS; Carey MP; Anderson VE; Carey PR; Bethel CR; Bonomo RA; Buynak JD; van den Akker F
J Am Chem Soc; 2006 Oct; 128(40):13235-42. PubMed ID: 17017804
[TBL] [Abstract][Full Text] [Related]
15. Pyrosequencing using the single-nucleotide polymorphism protocol for rapid determination of TEM- and SHV-type extended-spectrum beta-lactamases in clinical isolates and identification of the novel beta-lactamase genes blaSHV-48, blaSHV-105, and blaTEM-155.
Jones CH; Ruzin A; Tuckman M; Visalli MA; Petersen PJ; Bradford PA
Antimicrob Agents Chemother; 2009 Mar; 53(3):977-86. PubMed ID: 19075050
[TBL] [Abstract][Full Text] [Related]
16. Theoretical investigation on reaction of sulbactam with wild-type SHV-1 β-lactamase: acylation, tautomerization, and deacylation.
Li R; Liao JM; Gu CR; Wang YT; Chen CL
J Phys Chem B; 2011 Sep; 115(34):10298-310. PubMed ID: 21797222
[TBL] [Abstract][Full Text] [Related]
17. Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases.
Payne DJ; Cramp R; Winstanley DJ; Knowles DJ
Antimicrob Agents Chemother; 1994 Apr; 38(4):767-72. PubMed ID: 8031044
[TBL] [Abstract][Full Text] [Related]
18. The importance of the trans-enamine intermediate as a β-lactamase inhibition strategy probed in inhibitor-resistant SHV β-lactamase variants.
Ke W; Rodkey EA; Sampson JM; Skalweit MJ; Sheri A; Pagadala SR; Nottingham MD; Buynak JD; Bonomo RA; van den Akker F
ChemMedChem; 2012 Jun; 7(6):1002-8. PubMed ID: 22438274
[TBL] [Abstract][Full Text] [Related]
19. Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130.
Helfand MS; Bethel CR; Hujer AM; Hujer KM; Anderson VE; Bonomo RA
J Biol Chem; 2003 Dec; 278(52):52724-9. PubMed ID: 14534312
[TBL] [Abstract][Full Text] [Related]
20. Role of Asp104 in the SHV beta-lactamase.
Bethel CR; Hujer AM; Hujer KM; Thomson JM; Ruszczycky MW; Anderson VE; Pusztai-Carey M; Taracila M; Helfand MS; Bonomo RA
Antimicrob Agents Chemother; 2006 Dec; 50(12):4124-31. PubMed ID: 16982784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
